{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:04:47Z","timestamp":1780506287928,"version":"3.54.1"},"reference-count":46,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Tom and Susan Stepp","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA023108"],"award-info":[{"award-number":["P30CA023108"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA254042"],"award-info":[{"award-number":["R01CA254042"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA271553"],"award-info":[{"award-number":["R01CA271553"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA297297"],"award-info":[{"award-number":["R01CA297297"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM130454"],"award-info":[{"award-number":["P20GM130454"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,5,20]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic pre-conditioning prior to chimeric antigen receptor (CAR) T-cell infusion enhances engraftment and increases infiltration and activity of adoptively transferred cells within the tumor. Despite promising responses in some patients, additional strategies are needed to enhance overall efficacy of CAR T cells in patients with solid tumors. Armoring CAR T cells to express immunomodulatory cytokines can enhance treatment efficacy. In this study, we assess how systemic pre-conditioning impacts CAR T cells alone and in combination with interleukin (IL)-2 superkine (Sup2) and IL-33 cytokine armoring in the context of B16F10 melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Local and systemic pre-conditioning regimens were assessed in combination with TRP1-specific CAR T cells with or without Sup2 and IL-33 armoring in immunocompetent mice with B16F10 melanoma. CAR T-cell expansion kinetics and phenotype were evaluated with luminescence imaging, flow cytometry, and single-cell RNA sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Systemically preconditioned mice treated with Sup2-IL33 CAR T cells elicited greater tumor control and extended overall survival compared with non-conditioned or locally preconditioned mice. Depletion of Sup2-IL33 CAR T cells in preconditioned mice resulted in loss of durable tumor control. While total body irradiation (TBI) increased unarmored CAR T-cell engraftment, Sup2-IL33 armoring increased tumor infiltration of effector cells over TOX+exhausted\u2009cells. RNA velocity trajectory analysis predicted divergent differentiation of tumor-infiltrating progenitor cells into either effector or exhausted T cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Systemic preconditioning increased the expansion and persistence of transferred CAR T cells.<\/jats:p>\n                    <jats:p>TBI preconditioning in combination with cytokine armoring promoted the emergence of diverse effector phenotypes that correlated with enhanced efficacy of Sup2-IL33 CAR T cells in the context of B16F10 melanoma. Durable responsiveness and extended survival following combined therapy required continued CAR T-cell persistence despite the ability of Sup2-IL33 armoring to induce endogenous tumor immunity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-013020","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:15:12Z","timestamp":1780503312000},"page":"e013020","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapy"],"prefix":"10.1136","volume":"14","author":[{"given":"Shannon L","family":"Ferry","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Abdullah","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-8442","authenticated-orcid":false,"given":"Akshaya","family":"Balasubramanian","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8791-6166","authenticated-orcid":false,"given":"Elizabeth C","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Carl","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandrea","family":"Turnquist","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Cancer Biology, University of Virginia Beirne B Carter Center for Immunology Research, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Usherwood","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"},{"name":"Dartmouth Cancer Center, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sundrud","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"},{"name":"Department of Medicine, Dartmouth Health, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-9351","authenticated-orcid":false,"given":"Yina","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA"},{"name":"Dartmouth Cancer Center, Lebanon, New Hampshire, USA"},{"name":"Dartmouth College Geisel School of Medicine, Lebanon, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2026060309150614000_14.6.e013020.1","unstructured":"Sundararajan S , Thida AM , Yadlapati S , et al . Metastatic melanoma. In: StatPearls. Treasure Island (FL), 2025."},{"key":"2026060309150614000_14.6.e013020.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.5449"},{"key":"2026060309150614000_14.6.e013020.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00612"},{"key":"2026060309150614000_14.6.e013020.4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00262-019-02307-x","article-title":"Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2","volume":"68","author":"Nguyen","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"2026060309150614000_14.6.e013020.5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz011"},{"key":"2026060309150614000_14.6.e013020.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0297-y"},{"key":"2026060309150614000_14.6.e013020.7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0103"},{"key":"2026060309150614000_14.6.e013020.8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1811"},{"key":"2026060309150614000_14.6.e013020.9","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1158\/2326-6066.CIR-21-0536","article-title":"Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid Tumors","volume":"10","author":"Brog","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"2026060309150614000_14.6.e013020.10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10975","article-title":"Exploiting a natural conformational switch to engineer an interleukin-2 \u201csuperkine\u201d","volume":"484","author":"Levin","year":"2012","journal-title":"Nature New Biol"},{"key":"2026060309150614000_14.6.e013020.11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009994","article-title":"CD4 T cell depletion increases memory differentiation of endogenous and CAR T cells and enhances the efficacy of Super2 and IL-33-armored CAR T cells against solid tumors","volume":"13","author":"Mohamed","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026060309150614000_14.6.e013020.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00607-3"},{"key":"2026060309150614000_14.6.e013020.13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1303935","article-title":"Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle","volume":"14","author":"Lickefett","year":"2023","journal-title":"Front Immunol"},{"key":"2026060309150614000_14.6.e013020.14","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2026060309150614000_14.6.e013020.15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2153"},{"key":"2026060309150614000_14.6.e013020.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.12.003"},{"key":"2026060309150614000_14.6.e013020.17","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2158013","article-title":"Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors","volume":"12","author":"Laurent","year":"2023","journal-title":"Oncoimmunology"},{"key":"2026060309150614000_14.6.e013020.18","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-22-0840"},{"key":"2026060309150614000_14.6.e013020.19","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag1266","article-title":"The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications","volume":"1","author":"Spiotto","year":"2016","journal-title":"Sci Immunol"},{"key":"2026060309150614000_14.6.e013020.20","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAONCOL.2021.0168"},{"key":"2026060309150614000_14.6.e013020.21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200563"},{"key":"2026060309150614000_14.6.e013020.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1506-7"},{"key":"2026060309150614000_14.6.e013020.23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41419-023-05999-3","article-title":"New insights into the responder\/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy","volume":"14","author":"Uccello","year":"2023","journal-title":"Cell Death Dis"},{"key":"2026060309150614000_14.6.e013020.24","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood.V95.6.2024","article-title":"Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer","volume":"95","author":"Schiavoni","year":"2000","journal-title":"Blood"},{"key":"2026060309150614000_14.6.e013020.25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.8.4465"},{"key":"2026060309150614000_14.6.e013020.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"2026060309150614000_14.6.e013020.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01338-4"},{"key":"2026060309150614000_14.6.e013020.28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat Commun"},{"key":"2026060309150614000_14.6.e013020.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0414-6"},{"key":"2026060309150614000_14.6.e013020.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0591-3"},{"key":"2026060309150614000_14.6.e013020.31","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-019-1663-x","article-title":"PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells","volume":"20","author":"Wolf","year":"2019","journal-title":"Genome Biol"},{"key":"2026060309150614000_14.6.e013020.32","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181b88ffc"},{"key":"2026060309150614000_14.6.e013020.33","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1737369","article-title":"Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq","volume":"9","author":"Carmona","year":"2020","journal-title":"Oncoimmunology"},{"key":"2026060309150614000_14.6.e013020.34","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi3487","article-title":"Expansion of tumor-reactive CD8+ T cell clonotypes occurs in the spleen in response to immune checkpoint blockade","volume":"9","author":"Morgan","year":"2024","journal-title":"Sci Immunol"},{"key":"2026060309150614000_14.6.e013020.35","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn2337","article-title":"KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection","volume":"387","author":"Fagerberg","year":"2025","journal-title":"Science"},{"key":"2026060309150614000_14.6.e013020.36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25645-w","article-title":"Infection-induced type I interferons critically modulate the homeostasis and function of CD8+ na\u00efve T cells","volume":"12","author":"Jergovi\u0107","year":"2021","journal-title":"Nat Commun"},{"key":"2026060309150614000_14.6.e013020.37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature New Biol"},{"key":"2026060309150614000_14.6.e013020.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.10.009"},{"key":"2026060309150614000_14.6.e013020.39","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-02245-3","article-title":"Systemic tumor regression with synergy therapy: radiotherapy and CAR-T","volume":"10","author":"Ma","year":"2024","journal-title":"Cell Death Discov"},{"key":"2026060309150614000_14.6.e013020.40","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121910","article-title":"Application and Design of Switches Used in CAR","volume":"11","author":"G\u0142owacki","year":"2022","journal-title":"Cells"},{"key":"2026060309150614000_14.6.e013020.41","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-21-0515"},{"key":"2026060309150614000_14.6.e013020.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01477-2"},{"key":"2026060309150614000_14.6.e013020.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.09.013"},{"key":"2026060309150614000_14.6.e013020.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.06.013"},{"key":"2026060309150614000_14.6.e013020.45","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141629"},{"key":"2026060309150614000_14.6.e013020.46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.immuni.2023.01.029","article-title":"The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1+ CD8+ T cells in chronic viral infection","volume":"56","author":"Marx","year":"2023","journal-title":"Immunity"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-013020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:15:17Z","timestamp":1780503317000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-013020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,3]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/jitc-2025-013020"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-013020","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}